Logo image of ALKAL.PA

KALRAY SADIR (ALKAL.PA) Stock Fundamental Analysis

EPA:ALKAL - Euronext Paris - Matif - FR0010722819 - Common Stock - Currency: EUR

0.637  +0.02 (+3.41%)

Fundamental Rating

2

Taking everything into account, ALKAL scores 2 out of 10 in our fundamental rating. ALKAL was compared to 56 industry peers in the Semiconductors & Semiconductor Equipment industry. ALKAL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALKAL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALKAL had negative earnings in the past year.
In the past year ALKAL had a positive cash flow from operations.
In the past 5 years ALKAL always reported negative net income.
ALKAL had negative operating cash flow in 4 of the past 5 years.
ALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -26.40%, ALKAL is not doing good in the industry: 94.64% of the companies in the same industry are doing better.
With a Return On Equity value of -67.18%, ALKAL is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -26.4%
ROE -67.18%
ROIC N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ALKAL.PA Yearly ROA, ROE, ROICALKAL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

ALKAL has a better Gross Margin (114.61%) than 100.00% of its industry peers.
ALKAL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALKAL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 114.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
ALKAL.PA Yearly Profit, Operating, Gross MarginsALKAL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

ALKAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALKAL has been increased compared to 1 year ago.
The number of shares outstanding for ALKAL has been increased compared to 5 years ago.
ALKAL has a worse debt/assets ratio than last year.
ALKAL.PA Yearly Shares OutstandingALKAL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALKAL.PA Yearly Total Debt VS Total AssetsALKAL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -1.25, we must say that ALKAL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALKAL (-1.25) is worse than 91.07% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that ALKAL is not too dependend on debt financing.
ALKAL has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: ALKAL outperforms 48.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -1.25
ROIC/WACCN/A
WACC9.79%
ALKAL.PA Yearly LT Debt VS Equity VS FCFALKAL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

ALKAL has a Current Ratio of 0.62. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.
ALKAL's Current ratio of 0.62 is on the low side compared to the rest of the industry. ALKAL is outperformed by 92.86% of its industry peers.
ALKAL has a Quick Ratio of 0.62. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, ALKAL is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.53
ALKAL.PA Yearly Current Assets VS Current LiabilitesALKAL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALKAL have decreased strongly by -57.41% in the last year.
Looking at the last year, ALKAL shows a decrease in Revenue. The Revenue has decreased by -3.89% in the last year.
Measured over the past years, ALKAL shows a very strong growth in Revenue. The Revenue has been growing by 81.37% on average per year.
EPS 1Y (TTM)-57.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
Revenue 1Y (TTM)-3.89%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%31.62%

3.2 Future

ALKAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.40% yearly.
ALKAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.29% yearly.
EPS Next Y42.69%
EPS Next 2Y33.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-83.64%
Revenue Next 2Y-59.55%
Revenue Next 3Y67.4%
Revenue Next 5Y45.29%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALKAL.PA Yearly Revenue VS EstimatesALKAL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
ALKAL.PA Yearly EPS VS EstimatesALKAL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKAL. In the last year negative earnings were reported.
Also next year ALKAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKAL.PA Price Earnings VS Forward Price EarningsALKAL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALKAL.PA Per share dataALKAL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

ALKAL's earnings are expected to grow with 33.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALKAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KALRAY SADIR

EPA:ALKAL (7/23/2025, 7:00:00 PM)

0.637

+0.02 (+3.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-09 2025-07-09
Earnings (Next)09-17 2025-09-17
Inst Owners6.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.34M
Analysts40
Price Target0.51 (-19.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-80.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF 2.6
P/B 0.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)-1.27
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)0.25
OCFY38.46%
SpS2.15
BVpS3
TBVpS-1.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.4%
ROE -67.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 114.62%
FCFM N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
F-Score2
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 157.9%
Cap/Sales 137.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.53
Altman-Z -1.25
F-Score2
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)126.32%
Cap/Depr(5y)90.91%
Cap/Sales(3y)102.68%
Cap/Sales(5y)192.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
EPS Next Y42.69%
EPS Next 2Y33.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.89%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%31.62%
Revenue Next Year-83.64%
Revenue Next 2Y-59.55%
Revenue Next 3Y67.4%
Revenue Next 5Y45.29%
EBIT growth 1Y-77.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y231.64%
OCF growth 3YN/A
OCF growth 5YN/A